Van-Yu Wu

957 citations
33 papers · 833 indexed · h-index 17
Topics
Advanced Glycation End Products research (17 papers)Chronic Kidney Disease and Diabetes (12 papers)Cell Adhesion Molecules Research (6 papers)
Partner nations
United StatesFinland

In The Last Decade

Van-Yu Wu

33 papers receiving 778 citations

Peers

Van-Yu Wu
Comparison fields: 5 of 69
  • Clinical Biochemistry 430
  • Endocrinology, Diabetes and Metabolism 279
  • Nephrology 225
  • Molecular Biology 215
  • Cell Biology 140
Replace Carole Fages with:
Carole Fages Finland
Lionel J. Rosenzweig United States
Hironori Tamei Japan
Leifur Thorsteinsson Iceland
Georgia Dalagiorgou Greece
Bonnie Seidel-Rogol United States
Yefim Anbinder Israel
Greg Dietsch United States
Eun Ji Lee South Korea
Haymo Pircher Austria
Van-Yu Wu relative to Carole Fages Finland Carole Fages's profile →
Citations per field
00.5×7.0×
Carole Fages · 1×
Citations per year

Countries citing papers authored by Van-Yu Wu

Since Specialization
Citations

This map shows the geographic impact of Van-Yu Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Van-Yu Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Van-Yu Wu more than expected).

Fields of papers citing papers by Van-Yu Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Van-Yu Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Van-Yu Wu. The network helps show where Van-Yu Wu may publish in the future.

Co-authorship network of co-authors of Van-Yu Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Van-Yu Wu. A scholar is included among the top collaborators of Van-Yu Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Van-Yu Wu. Van-Yu Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 4
2 18
3 39
4 19
5 121
6 33
7 20
8 35
9 53
10 19
11 7
12 8
13 48
14 1
15 55
16 6
17 42
18 122
19 4
20 3

About Van-Yu Wu

Van-Yu Wu is a scholar working on Clinical Biochemistry, Nephrology and Immunology and Allergy, having authored 33 papers that have together received 833 indexed citations. Recurring topics across this work include Advanced Glycation End Products research (17 papers), Chronic Kidney Disease and Diabetes (12 papers) and Cell Adhesion Molecules Research (6 papers). The work is most often cited by research in Clinical Biochemistry (430 citations), Nephrology (225 citations) and Endocrinology, Diabetes and Metabolism (279 citations). Van-Yu Wu has collaborated with scholars based in United States and Finland. Frequent co-authors include Margo P. Cohen, Maria Surma, Elizabeth Hud, Enrique Urdanivia, Margo P. Cohen, Fuad N. Ziyadeh, Bryan Wilson, John Tomaszewski, Ying Jin and Kumar Sharma. Their work appears in journals such as Journal of Clinical Investigation, Diabetes and Analytical Biochemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026